Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 09 - 28    tags : Approval    save search

Nanotech Security Corp. Announces Securityholder Approval of Arrangement with Meta Materials Inc.
Published: 2021-09-28 (Crawled : 00:00) - globenewswire.com
MMAT | $2.54 -3.05% -3.15% 160K twitter stocktwits trandingview |
Mining, Quarrying, and Oil and ...
| | O: 0.16% H: 5.31% C: -8.04%

security approval
Navient, Maximus Announce Proposal to Transfer Federal Student Loan Servicing Contract, Pending Government Approval
Published: 2021-09-28 (Crawled : 21:00) - globenewswire.com
MMS 4 | $81.44 1.75% 0.0% 280K twitter stocktwits trandingview |
Commercial Services
| | O: 0.37% H: 1.4% C: 0.98%
AVNT | $42.52 0.38% -0.12% 620K twitter stocktwits trandingview |
Process Industries
| | O: -0.13% H: 0.9% C: 0.57%
NAVI | $16.19 -0.43% -0.43% 1.1M twitter stocktwits trandingview |
Finance
| | O: 0.07% H: 0.51% C: -13.97%

contract approval
Grupo Aeroportuario Del Pacifico Pays Capital Stock Reduction Approved at the Extraordinary Shareholders’ Meeting
Published: 2021-09-28 (Crawled : 21:00) - globenewswire.com
PAC | $156.15 0.16% 0.0% 42K twitter stocktwits trandingview |
Transportation
| | O: 0.63% H: 0.0% C: -1.1%

approval
Navigator Gas awarded approval in principle for ammonia fuelled gas carrier by classification society DNV
Published: 2021-09-28 (Crawled : 15:00) - navigatorgas.com
NVGS | $14.97 0.94% 0.0% 170K twitter stocktwits trandingview |
Transportation
| | O: 0.81% H: 2.86% C: 0.8%
BW | News | $0.9279 -4.18% 0.0% 1.1M twitter stocktwits trandingview |
Electronic Technology
| | O: 0.15% H: 5.86% C: -2.0%

approval
Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio
Published: 2021-09-28 (Crawled : 06:00) - prnewswire.com
MDT | $79.48 0.37% -0.29% 6.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.73% H: 0.1% C: -1.42%

ce mark approval
Eisai Initiates Rolling Submission To The U.S. FDA For Biologics License Application Of Lecanemab (BAN2401) For Early Alzheimer's Disease Under The Accelerated Approval Pathway
Published: 2021-09-28 (Crawled : 06:00) - biospace.com/
BIIB | $194.39 2.03% 1.99% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.47% H: 0.25% C: -2.1%

disease alzheimer fda license approval submission alzheimer’s alzheimer's disease alzheimer's lecanemab
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.